UBS Maintains Thermo Fisher Scientific to Buy with Price Target $176.00

Brokerage firm UBS Maintains its rating on Thermo Fisher Scientific(NYSE:TMO). In a research note issued to the investors, the brokerage major Raises the price-target to $176.00 per share. The shares have been rated Buy. The rating by UBS was issued on Sep 21, 2016.

In a different note, On Sep 9, 2016, Cleveland Research said it Downgrades its rating on Thermo Fisher Scientific. The shares have been rated ‘Neutral’ by the firm. On Jul 29, 2016, Citigroup said it Maintains its rating on Thermo Fisher Scientific. In the research note, the firm Raises the price-target to $160.00 per share. The shares have been rated ‘Buy’ by the firm. On Jul 22, 2016, BTIG Research said it Assumes its rating on Thermo Fisher Scientific. The shares have been rated ‘Buy’ by the firm. On Jul 19, 2016, Barclays said it Maintains its rating on Thermo Fisher Scientific. In the research note, the firm Raises the price-target to $170.00 per share. The shares have been rated ‘Overweight’ by the firm.

Thermo Fisher Scientific (TMO) made into the market gainers list on Tuesdays trading session with the shares advancing 1.08% or 1.62 points. Due to strong positive momentum, the stock ended at $151.62, which is also near the day’s high of $152.53. The stock began the session at $151.37 and the volume stood at 14,88,167 shares. The 52-week high of the shares is $160.675 and the 52 week low is $117.1. The company has a current market capitalization of $59,778 M and it has 39,42,62,870 shares in outstanding.

Thermo Fisher Scientific(TMO) last announced its earnings results on Jul 28, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $4.54B. Analysts had an estimated revenue of $4.50B. Earnings per share were $2.03. Analysts had estimated an EPS of $2.01.

Several Insider Transactions has been reported to the SEC. On Sep 6, 2016, Marc N Casper (Chief Executive Officer) sold 28,797 shares at $151.01 per share price.Also, On Aug 31, 2016, Daniel P Shine (Senior Vice President) sold 1,699 shares at $152.28 per share price.On Aug 31, 2016, Thomas W Loewald (Senior Vice President) sold 3,256 shares at $152.28 per share price, according to the Form-4 filing with the securities and exchange commission.

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Thermo Fisher Scientific - Is it time to Sell?

Top Brokerage Firms are advising their investors on Thermo Fisher Scientific. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.